|
시장보고서
상품코드
2051141
서방형 약물전달 시장 : 기술별, 치료 분야별, 용도별, 지역별Controlled Release Drug Delivery Market, By Technology, By Therapeutic Area, By Application, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
서방형 약물전달 시장은 2026년에 646억 달러로 추정되며, 2033년까지 1,340억 8,000만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 11.0%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 646억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 11.00% | 2033년 금액 예측: | 1,340억 8,000만 달러 |
서방형 전달 메커니즘은 의약품의 유효 성분이나 약물을 몇 시간에서 며칠에 걸쳐 장기간에 걸쳐 전달할 수 있도록 도와줍니다. 이는 기존 약물전달 방식에 비해 투여 빈도 감소, 치료 효과 향상, 부작용 감소 등 여러 가지 이점을 제공합니다. 만성질환 유병률 증가, 고령 인구 증가, 주요 기업들의 R&D 투자 확대, 기술 발전 등의 요인이 시장 성장을 견인할 것으로 보입니다. 그러나 서방형 제품 개발에 따른 높은 비용과 엄격한 규제 승인 절차는 시장 진입 기업에게 도전이 될 수 있습니다.
시장 역학
세계 서방형 약물전달 시장의 성장은 당뇨병, 암, 심혈관질환과 같은 만성 질환의 유병률 증가에 의해 주도되고 있습니다. 세계보건기구(WHO)에 따르면, 2021년 전 세계 사망 원인의 70% 이상을 만성질환이 차지했습니다. 서방형 의약품은 장기간에 걸쳐 체내 약물 농도를 일정하게 유지함으로써 만성질환의 관리 개선에 기여합니다. 만성질환에 취약한 고령 인구의 증가도 시장 성장을 촉진할 수 있습니다. 그러나 서방형 약물전달 개발에 따른 높은 비용과 장기간의 임상시험은 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 서방형 약물전달 메커니즘의 기술적 진보, 지속형 의약품에 대한 선호도 증가, 희귀 질환을 위한 전문 의약품 개발에 대한 집중은 시장 관계자들에게 성장 기회를 제공할 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 서방형 약물전달 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계 서방형 약물전달 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 서방형 약물전달 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 서방형 약물전달 시장 : 기술별, 2021-2033년
제5장 세계의 서방형 약물전달 시장 : 치료 분야별, 2021-2033년
제6장 세계의 서방형 약물전달 시장 : 용도별, 2021-2033년
제7장 세계의 서방형 약물전달 시장 : 유통 채널별, 2021-2033년
제8장 세계의 서방형 약물전달 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고문헌 및 조사 방법
KSM 26.06.16Controlled Release Drug Delivery Market is estimated to be valued at USD 64.60 Bn in 2026 and is expected to reach USD 134.08 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 64.60 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.00% | 2033 Value Projection: | USD 134.08 Bn |
Controlled release delivery mechanism helps in delivering a pharmaceutical active compound or drug over an extended period of time, from hours to days. It offers several advantages over conventional drug delivery such as reduced dosing frequency, better therapeutic effectiveness and lower side effects. Factors such as growing prevalence of chronic diseases, rising geriatric population, increasing R&D investments by major players and technological advancements can drive the market growth. However, high costs associated with developing controlled release products and stringent regulatory approval process can pose challenges for the market players.
Market Dynamics
Global controlled release drug delivery market growth is driven by rising prevalence of chronic diseases such as diabetes, cancer and cardiovascular diseases. According to the WHO, chronic diseases accounted for over 70% deaths worldwide in 2021. Controlled release drugs help in better management of chronic conditions through constant drug levels in the body over an extended time period. Growing geriatric population prone to chronic illnesses can also drive the market growth. However, high costs associated with developing controlled release formulations and long duration of clinical trials can hamper the market growth. Technological advancements in controlled release drug delivery mechanisms, growing preference for long-acting pharmaceuticals, and focus on developing specialty drugs for orphan diseases can offer growth opportunities for market players.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global controlled release drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Depomed, Coating Place, Corium, and Johnson and Johnson
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global controlled release drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global controlled release drug delivery market.
Market Segmentation
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Transdermal
- Targeted Delivery
- Others
- Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
- Infectious Diseases
- Oncology
- Cardiology
- Neurology
- Autoimmune Diseases
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Metered Dose Inhalers
- Injectables
- Infusion Pumps
- Drug Eluting Stents
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes plc
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc
- Aradigm Corporation
- Capsugel
- Abbott Laboratories
- Roche Holdings AG
- AstraZeneca
- Baxter International Inc
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Controlled Release Drug Delivery Market, By Technology, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Wurster Technique
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Coacervation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Micro Encapsulation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Transdermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Targeted Delivery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Controlled Release Drug Delivery Market, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Controlled Release Drug Delivery Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Metered Dose Inhalers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Injectables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Infusion Pumps
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Drug Eluting Stents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Controlled Release Drug Delivery Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Controlled Release Drug Delivery Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Orbis Biosciences, Inc.
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck and Co., Inc.
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alkermes plc
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson and Johnson
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Coating Place, Inc.
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Corium International, Inc.
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Depomed, Inc.
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aradigm Corporation
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Capsugel.
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Roche Holdings AG
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Baxter International Inc
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Therapeutic Area Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Orbis Biosciences, Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
